- ►annals.org LM Buckley, ES Leib, KS Cartularo, PM … - Annals of internal medicine, 1996 - Am Coll Physicians Background: Therapy with low-dose corticosteroids is commonly used to treat
allergic and autoimmune diseases. Long-term use of corticosteroids can lead to
loss of bone mineral density and higher risk for vertebral fractures. ... Cited by 250 - Related articles - All 6 versions
JD Adachi, WG Bensen, F Bianchi, A Cividino, … - The Journal of rheumatology, 1996 - ncbi.nlm.nih.gov OBJECTIVE: To determine the efficacy and safety of vitamin D 50,000 units/week
and calcium 1,000 mg/day in the prevention of corticosteroid induced
osteoporosis. METHODS: A minimized double blind, placebo controlled trial ... Cited by 184 - Related articles - BL Direct - All 3 versions
P Sambrook, J Birmingham, P Kelly, S … - New England Journal of Medicine, 1993 - content.nejm.org Methods One hundred three patients starting long-term corticosteroid therapy
were randomly assigned to receive 1000 mg of calcium per day orally and either
calcitriol (0.5 to 1.0 µg per day orally) plus salmon calcitonin (400 IU ... Cited by 402 - Related articles - BL Direct - All 8 versions
GM Hall, M Daniels, DV Doyle, TD Spector, C … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 183 - Related articles - BL Direct - All 4 versions
JY Reginster, D Kuntz, W Verdickt, M Wouters, … - Osteoporosis International, 1999 - Springer Abstract. One hundred and forty-five patients suffering from diseases requiring
long-term treatment with high doses of corticosteroids (30 mg/day or greater of
prednisolone) were recruited to the study. Patients had to be steroid naive ... Cited by 101 - Related articles - BL Direct - All 5 versions
- ►psu.edu [PDF] JD Adachi, WG Bensen, J Brown, D Hanley, A … - The New England journal of medicine, 1997 - nejm.highwire.org Background and Methods Osteoporosis is a recognized complication of
corticosteroid therapy. Whether it can be prevented is not known. We conducted a
12-month, randomized, placebo-controlled study of intermittent etidronate ... Cited by 579 - Related articles - BL Direct - All 9 versions
BP Lukert, BE Johnson, RG Robinson - J Bone Miner Res, 1992 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Estrogen and progesterone
replacement therapy reduces glucocorticoid-induced bone loss. ... Cited by 173 - Related articles - Cached - All 3 versions
TR Dykman, KM Haralson, OS Gluck, WA … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 101 - Related articles - All 3 versions
- ►oxfordjournals.org [PDF] JD Adachi, WG Bensen, MJ Bell, FA Bianchi, … - Rheumatology, 1997 - Br Soc Rheumatology The objectives were to determine the efficacy and safety of nasal salmon
calcitonin 200 IU daily in the prevention of corticosteroid-induced
osteoporosis. A minimized, double-blind, placebo-controlled trial was ... Cited by 84 - Related articles - BL Direct - All 5 versions
- ►bmj.com [PDF] M Luengo, F Pons, MJ Martinez de Osaba, C … - British Medical Journal, 1994 - thorax.bmj.com Abstract Background - Injectable calcitonin is effective in reducing spinal bone
loss in steroid-dependent asthma but side effects are frequent. In contrast, a
nasal spray presentation hasbeen shown to be effective and well tolerated ... Cited by 77 - Related articles - BL Direct - All 7 versions
